The health care world was aflutter yesterday over a report in the industry publication Reorg Research that says antitrust officials at the Department of Justice won’t challenge CVS Health’s $69 billion acquisition of Aetna, and may send an approval memo as soon as the end of this month.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,